Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041746 | SCV000065442 | benign | not specified | 2011-06-21 | criteria provided, single submitter | clinical testing | Ser4588Tyr in exon 63 of USH2A: This variant is predicted to be benign based on its high frequency in the general population (dbSNP rs78253373). |
Gene |
RCV000041746 | SCV000515238 | benign | not specified | 2015-07-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000880724 | SCV000605539 | benign | not provided | 2022-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000880724 | SCV001023843 | benign | not provided | 2025-01-12 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504923 | SCV002794882 | likely benign | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2021-07-29 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450777 | SCV004183133 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001276153 | SCV004183134 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000880724 | SCV005287602 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001276153 | SCV001462007 | benign | Usher syndrome type 2A | 2020-09-16 | no assertion criteria provided | clinical testing |